RxDoctor Payments Data

Brian Whyte, MD

Surgery · Beckley, WVNPI 1407965668

Payments from drug & device makers

What this record shows

This record is dominated by other: $36,500 of the $56,112 with a category attached, or 65.0%. Angiodynamics, Inc. accounts for 69.3% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $30,812 and has fallen 86.9% since, to $4,050 in 2025. Among surgery clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,112in general payments, 2019–2025

Across 273 payments — averaging $205.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$39K
  • Boston Scientific$8K
  • Bolton Medical Inc$2K
  • Silk Road Medical, Inc.$1K
  • Shockwave Medical, Inc$1K
  • Terumo Medical Corporation$844
  • plus $5K from 22 others

What the payments were for

  • Travel & lodging$8,36715%
  • Food & beverage$11,23220%
  • Education$130%
  • Other$36,50065%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,112 in reported general payments places this provider in the 95th percentile of 162 surgery providers in West Virginia.

See all surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$463,409
Medicare patients
532
Services billed
2,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban96$71,058
XareltoRivaroxaban85$56,271
BrilintaTicagrelor12$5,538
ClopidogrelClopidogrel Bisulfate391$3,025
Cilostazol141$1,404
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$171
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$77
Prednisone19$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$124$71,05896 claims
Johnson & JohnsonXarelto$584$56,27185 claims
AstraZenecaBrilinta$76$5,53812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 162 surgery providers in West Virginia.

Other surgery in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →